Prelude Therapeutics Incorporated (PRLD)

Prelude Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	25.75	12.47	25.29	30.61	31.83	218.31
Short-Term Investments	47.46	121.14	207.64	171.12	259.41	-
Cash & Short-Term Investments	73.22	133.61	232.94	201.73	291.23	218.31
Cash Growth	-59.29%	-42.64%	15.47%	-30.73%	33.40%	1056.36%
Prepaid Expenses	3.66	2.28	2.65	2.65	3.88	2.5
Total Current Assets	76.88	135.9	235.59	204.38	295.12	220.81
Property, Plant & Equipment	33.89	35.47	37.74	6.7	5.64	2.48
Other Long-Term Assets	4.15	4.15	4.34	9.42	4.35	0.3
Total Assets	114.92	175.52	277.67	220.5	305.1	223.59
Accounts Payable	4.96	7.73	4.58	6.78	7.84	3.92
Accrued Expenses	12.37	14.44	14.82	12.57	9.53	7.04
Current Portion of Leases	2.71	2.7	1.48	1.83	1.74	-
Other Current Liabilities	0.86	0.77	0.95	0.52	0.09	0.42
Total Current Liabilities	20.91	25.64	21.83	21.7	19.2	11.38
Long-Term Leases	15.21	15.33	15.41	-	-	-
Other Long-Term Liabilities	2.97	3.09	3.34	3.36	-	0.03
Total Liabilities	39.08	44.06	40.58	25.06	19.2	11.41
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	722.71	714.98	693.25	531.68	505.72	319.61
Retained Earnings	-646.88	-583.56	-456.39	-334.56	-219.12	-107.43
Comprehensive Income & Other	-0	0.04	0.22	-1.69	-0.71	-
Total Common Equity	75.84	131.46	237.09	195.44	285.9	212.18
Shareholders' Equity	75.84	131.46	237.09	195.44	285.9	212.18
Total Liabilities & Equity	114.92	175.52	277.67	220.5	305.1	223.59
Total Debt	17.92	18.03	16.89	1.83	1.74	-
Net Cash (Debt)	55.3	115.59	216.05	199.9	289.49	218.31
Net Cash Growth	-65.79%	-46.50%	8.08%	-30.95%	32.61%	1072.38%
Net Cash Per Share	0.73	1.52	3.58	4.22	6.29	17.49
Filing Date Shares Outstanding	56.6	55.15	54.89	47.71	47.02	45.37
Total Common Shares Outstanding	56.59	55.15	54.89	47.7	46.99	42.49
Working Capital	55.97	110.25	213.76	182.68	275.91	209.43
Book Value Per Share	1.34	2.38	4.32	4.10	6.08	4.99
Tangible Book Value	75.84	131.46	237.09	195.44	285.9	212.18
Tangible Book Value Per Share	1.34	2.38	4.32	4.10	6.08	4.99
Machinery	-	10.33	8.97	5.72	4.38	2.72
Construction In Progress	-	-	0.34	1.64	0.67	-
Leasehold Improvements	-	1.7	1.58	0.88	0.88	0.45

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q